Physician profile
Scott Strickler
NPI 1043744477
$666.85
in general payments reported to CMS, 2019-2025
11 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.03 · 2023: $110 · 2024: $183 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $149.45 | 2024-2025 | Optune Gio, Optune |
| Monteris Medical Corporation | $128.04 | 2024 | Neuroblate |
| Stemline Therapeutics INC. | $119.16 | 2025 | Orserdu |
| Janssen Biotech, INC. | $74.60 | 2025 | Rybrevant |
| Elekta, INC. | $46.16 | 2023 | Elekta Medical Linear Accelerator |
| Siemens Medical Solutions USA, INC. | $39.99 | 2023 | Halcyon |
| Daiichi Sankyo INC. | $24.28 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.25 | 2023 | |
| Sumitomo Pharma America, INC. | $23.63 | 2024 | Orgovyx |
| Astrazeneca Pharmaceuticals LP | $20.26 | 2025 | |
| Ambu INC. | $17.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Strickler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.